CYP8B1 activators are a class of compounds that influence the activity of the enzyme cytochrome P450 8B1, which is primarily involved in the synthesis of bile acids from cholesterol. Bile acids are not only crucial for dietary lipid absorption but also serve as signaling molecules that can regulate their own synthesis through feedback mechanisms. Compounds such as cholic acid and chenodeoxycholic acid directly participate in the enterohepatic circulation of bile acids, and their levels can signal the need for the liver to synthesize more bile acids. This increase in bile acid synthesis demand can indirectly enhance CYP8B1 activity, as this enzyme is critical in the synthesis pathway of bile acids. Similarly, the presence of deoxycholic acid and lithocholic acid, which are secondary bile acids formed from primary bile acids by bacterial action in the intestine, can indicate to the liver that there is a need for increased synthesis of bile acids, thus potentially enhancing the activity of CYP8B1.
Moreover, compounds such as glycocholic acid and tauroursodeoxycholic acid can modulate the demand for bile acid synthesis by altering the bile acid composition and pool sizes. This modulation can indirectly increase CYP8B1 activity, as the enzyme is essential in the synthesis of these bile acids. Ursodeoxycholic acid and beta-muricholic acid similarly influence CYP8B1 by affecting the bile acid pools. Moreover, compounds like nicotinamide impact lipid metabolism pathways, which may have downstream effects on the synthesis of bile acids, thereby affecting CYP8B1 activity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cholic acid | 81-25-4 | sc-255020 sc-255020A sc-255020B sc-255020C sc-255020D | 25 g 100 g 500 g 1 kg 5 kg | $49.00 $123.00 $578.00 $1018.00 $4570.00 | 11 | |
Cholic acid can upregulate CYP8B1 by increasing the demand for bile acid synthesis, as CYP8B1 catalyzes a step in the biosynthesis of cholic acid from cholesterol. | ||||||
Chenodeoxycholic acid, free acid | 474-25-9 | sc-278835 sc-278835A | 1 g 5 g | $28.00 $117.00 | ||
Elevated concentrations of chenodeoxycholic acid signal the liver to synthesize more bile acids, thereby indirectly enhancing CYP8B1 activity, which is a key enzyme in this process. | ||||||
Deoxycholic acid | 83-44-3 | sc-214865 sc-214865A sc-214865B | 5 g 25 g 1 kg | $37.00 $67.00 $941.00 | 4 | |
Deoxycholic acid, when reabsorbed, may induce the synthesis of more bile acids, indirectly necessitating increased CYP8B1 activity for its role in bile acid biosynthesis from cholesterol. | ||||||
Lithocholic acid | 434-13-9 | sc-215262 sc-215262A | 10 g 25 g | $100.00 $272.00 | 1 | |
Lithocholic acid serves as a substrate for CYP8B1 and its increased presence in the liver could enhance the enzyme's activity through substrate-induced upregulation. | ||||||
Glycocholic acid | 475-31-0 | sc-218574 sc-218574A sc-218574B sc-218574C sc-218574D sc-218574E | 100 mg 1 g 5 g 10 g 50 g 100 g | $73.00 $188.00 $680.00 $1259.00 $1675.00 $3131.00 | 4 | |
Glycocholic acid, as a conjugated bile acid, may enhance CYP8B1 activity by increasing demand for bile acid synthesis, as conjugated bile acids are found in primary bile acids that CYP8B1 helps to synthesize. | ||||||
Tauroursodeoxycholic Acid, Sodium Salt | 14605-22-2 | sc-281165 | 1 g | $644.00 | 5 | |
Tauroursodeoxycholic acid may enhance CYP8B1 activity by altering bile acid homeostasis and thus increasing the synthesis of bile acids where CYP8B1 is a key enzyme. | ||||||
Ursodeoxycholic acid | 128-13-2 | sc-204935 sc-204935A | 1 g 5 g | $52.00 $131.00 | 4 | |
Ursodeoxycholic acid can enhance CYP8B1 function by modulating bile acid pools and signaling the liver to increase bile acid synthesis, in which CYP8B1 is involved. | ||||||
Nicotinamide | 98-92-0 | sc-208096 sc-208096A sc-208096B sc-208096C | 100 g 250 g 1 kg 5 kg | $44.00 $66.00 $204.00 $831.00 | 6 | |
Nicotinamide can influence lipid metabolism which may enhance CYP8B1 activity indirectly by modulating the synthesis of bile acids. | ||||||
CHOLESTYRAMINE RESIN | 11041-12-6 | sc-507509 | 5 g | $210.00 | ||
Cholestyramine can enhance CYP8B1 activity by sequestering bile acids in the intestines, decreasing their reabsorption, and thus increasing the demand for hepatic synthesis of bile acids, where CYP8B1 is involved. | ||||||